TechFlow reports that 21Shares has launched the Injective Staking ETP (AINJ) on Euronext, tracking the performance of Injective (INJ) and capturing staking yields. AINJ holds $128.6 million in assets under management, carries a 2.5% fee, and is backed by physically held INJ stored in cold storage. Current staking rewards for Injective are approximately 19.38%.
Navigating Web3 tides with focused insights
Contribute An Article
Media Requests
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / [email protected] ICP License: 琼ICP备2022009338号




